Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • drug

    Tag: drug

    You Searched For "drug"
    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

    Farhat Nasim13 May 2019 10:31 AM IST
    Zydus Cadila said Chlorthalidone tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug...
    Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder

    Jacobus Pharma wins USFDA approval for Ruzurgi to treat rare autoimmune disorder

    Medical Dialogues Bureau7 May 2019 9:25 AM IST
    The drug, Ruzurgi, was approved for use in patients aged between 6 and 17, the FDA said Lambert-Eaton myasthenic syndrome, which affects about three...
    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Glenmark Pharma gets USFDA approval for generic version of VAGIFEM

    Farhat Nasim25 April 2019 10:50 AM IST
    The approved product Estradiol Vaginal Inserts USP, 10 mcg is a generic version of Novo Nordisk Inc's VAGIFEM. New Delhi: Glenmark Pharmaceuticals has...
    Cipla gets 8 USFDA observations for Kurkumbh plant

    Cipla gets 8 USFDA observations for Kurkumbh plant

    Farhat Nasim1 April 2019 9:55 AM IST
    The inspection covered three units at the plant. Post the conclusion of the inspection, the company received 8 GMP observations. The company also...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 1:33 PM IST
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    Lupin to lays off employees from RnD Divsion

    Lupin to lays off employees from RnD Divsion

    Farhat Nasim15 March 2019 6:01 PM IST
    Mumbai: Facing a Setback in its business turf, one the largest manufacturers of medicines in the country Lupin Ltd is taking steps to rationalize its...
    French court dismisses damage claims against Merck over Levothyrox

    French court dismisses damage claims against Merck over Levothyrox

    Farhat Nasim8 March 2019 9:15 AM IST
    The plaintiffs had accused Merck of not providing sufficient information regarding changes to the Levothyrox.France: A court in the French city of...
    Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril

    Lupin posts Q3 loss of Rs 152 crore on litigation over Perindopril

    Farhat Nasim7 Feb 2019 2:23 PM IST
    Lupin had a net loss of 1.52 billion rupees compared to a profit of 2.22 billion rupees in the same quarter last year, the company said.Mumbai: A...
    Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

    Glenmark gets tentative USFDA nod for Abiraterone Acetate tablets

    Medical Dialogues Bureau24 Jan 2019 9:30 AM IST
    Glenmark Pharmaceuticals Inc USA has been granted tentative approval by the United States Food and Drug Administration for Abiraterone Acetate tablets...
    Launch of User Manual on SUGAM portal: CDSCO

    Launch of User Manual on SUGAM portal: CDSCO

    Medical Dialogues Bureau2 Dec 2018 12:00 PM IST
    New Delhi: Through a public notice released on 29.11.2018 Central Drugs Standard Control Organisation(CDSCO) has announced the launch of a User...
    Loxo,Bayer gets U.S approval for cancer drug Larotrectinib

    Loxo,Bayer gets U.S approval for cancer drug Larotrectinib

    Medical Dialogues Bureau28 Nov 2018 9:06 AM IST
    New Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...
    FDA approves new blood cancer treatment from Pfizer

    FDA approves new blood cancer treatment from Pfizer

    Medical Dialogues Bureau22 Nov 2018 9:15 AM IST
    The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's drug to treat a form of blood cancer in newly diagnosed patients as a...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok